Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 42Observational 4Expanded_access 1

Sponsor

Cancer Type

Genitourinary 3Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 3Liver Neoplasms 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Observational × cabozantinib × Clear all
NCT05100082 2025-12-30

Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma

Takeda

Completed
263 enrolled
Gastrointestinal

Liver Neoplasms

NCT04804813 2025-04-11

Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

Takeda

Completed
388 enrolled 20 charts
Genitourinary

Carcinoma, Renal Cell

NCT04353765 2021-11-17

US NIS Cabo

Ipsen

Completed
247 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04637204 2021-02-01

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Ipsen

Completed
1,540 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡